BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18394724)

  • 1. Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus.
    Chung DH; Kumarapperuma SC; Sun Y; Li Q; Chu YK; Arterburn JB; Parker WB; Smith J; Spik K; Ramanathan HN; Schmaljohn CS; Jonsson CB
    Antiviral Res; 2008 Jul; 79(1):19-27. PubMed ID: 18394724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro.
    McDowell M; Gonzales SR; Kumarapperuma SC; Jeselnik M; Arterburn JB; Hanley KA
    Antiviral Res; 2010 Jul; 87(1):78-80. PubMed ID: 20416341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5,6-Dichloro-2-phenyl-benzotriazoles: New Potent Inhibitors of Orthohantavirus.
    Sanna G; Piras S; Madeddu S; Busonera B; Klempa B; Corona P; Ibba R; Murineddu G; Carta A; Loddo R
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31968537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of SYBR green-based qPCR assay for rapid evaluation and quantification for anti-Hantaan virus compounds in vitro and in suckling mice.
    Wei F; Li JL; Ling JX; Chen LJ; Li N; Liu YY; Luo F; Xiong HR; Hou W; Yang ZQ
    Virus Genes; 2013 Feb; 46(1):54-62. PubMed ID: 23054436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus.
    Chung DH; Sun Y; Parker WB; Arterburn JB; Bartolucci A; Jonsson CB
    J Virol; 2007 Nov; 81(21):11722-9. PubMed ID: 17699579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activity of ribavirin against Andes virus infection.
    Safronetz D; Haddock E; Feldmann F; Ebihara H; Feldmann H
    PLoS One; 2011; 6(8):e23560. PubMed ID: 21853152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological analysis of hemorrhagic fever with renal syndrome (HFRS) patients in Far Eastern Russia and identification of the causative hantavirus genotype.
    Miyamoto H; Kariwa H; Araki K; Lokugamage K; Hayasaka D; Cui BZ; Lokugamage N; Ivanov LI; Mizutani T; Iwasa MA; Yoshimatsu K; Arikawa J; Takashima I
    Arch Virol; 2003 Aug; 148(8):1543-56. PubMed ID: 12898330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.
    Sun Y; Chung DH; Chu YK; Jonsson CB; Parker WB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):84-8. PubMed ID: 17060520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of in vitro and in vivo antiviral activity of lactoferrin and ribavirin upon hantavirus.
    Murphy ME; Kariwa H; Mizutani T; Tanabe H; Yoshimatsu K; Arikawa J; Takashima I
    J Vet Med Sci; 2001 Jun; 63(6):637-45. PubMed ID: 11459009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The murine model for Hantaan virus-induced lethal disease shows two distinct paths in viral evolutionary trajectory with and without ribavirin treatment.
    Chung DH; Västermark Å; Camp JV; McAllister R; Remold SK; Chu YK; Bruder C; Jonsson CB
    J Virol; 2013 Oct; 87(20):10997-1007. PubMed ID: 23903835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maporal virus as a surrogate for pathogenic New World hantaviruses and its inhibition by favipiravir.
    Buys KK; Jung KH; Smee DF; Furuta Y; Gowen BB
    Antivir Chem Chemother; 2011 May; 21(5):193-200. PubMed ID: 21566265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-cell Western assay to quantify infection with pathogenic orthohantavirus Puumala virus in replication kinetics and antiviral drug testing.
    Nusshag C; Schreiber P; Uhrig J; Zeier M; Krautkrämer E
    Virus Res; 2023 Nov; 337():199230. PubMed ID: 37777116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hantavirus causing hemorrhagic fever with renal syndrome requires gC1qR/p32 for efficient cell binding and infection.
    Choi Y; Kwon YC; Kim SI; Park JM; Lee KH; Ahn BY
    Virology; 2008 Nov; 381(2):178-83. PubMed ID: 18834607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW; Josleyn M; Ballantyne J; Brocato R
    Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
    Westover JB; Sefing EJ; Bailey KW; Van Wettere AJ; Jung KH; Dagley A; Wandersee L; Downs B; Smee DF; Furuta Y; Bray M; Gowen BB
    Antiviral Res; 2016 Feb; 126():62-8. PubMed ID: 26711718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nucleosides of 1,2,4-triazole: potentialities and restrictions of chemo-enzymatic method for synthesis].
    Konstantinova ID; Chudinov MV; Fateev IV; Matveev AV; Zhurilo NI; Shvets VI; Miroshnikov AI
    Bioorg Khim; 2013; 39(1):61-80. PubMed ID: 23844508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins.
    Gavrilovskaya IN; Brown EJ; Ginsberg MH; Mackow ER
    J Virol; 1999 May; 73(5):3951-9. PubMed ID: 10196290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemorrhagic fever with renal syndrome and Crimean-Congo hemorrhagic fever as causes of acute undifferentiated febrile illness in Bulgaria.
    Christova I; Younan R; Taseva E; Gladnishka T; Trifonova I; Ivanova V; Spik K; Schmaljohn C; Mohareb E
    Vector Borne Zoonotic Dis; 2013 Mar; 13(3):188-92. PubMed ID: 23421884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hantavirus pulmonary syndrome.
    Macneil A; Nichol ST; Spiropoulou CF
    Virus Res; 2011 Dec; 162(1-2):138-47. PubMed ID: 21945215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses.
    Kraus AA; Raftery MJ; Giese T; Ulrich R; Zawatzky R; Hippenstiel S; Suttorp N; Krüger DH; Schönrich G
    J Virol; 2004 Jun; 78(12):6143-50. PubMed ID: 15163707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.